Genetic
1966, Austria — Dr. Andreas Rett's initial German-language clinical observations and publications
Rett syndrome was first formally described in the mid-twentieth century by Austrian pediatric neurologist Andreas Rett, who identified a distinctive pattern of neurological regression in young girls. For decades after its initial description, the condition remained poorly understood and was frequently misidentified as autism, cerebral palsy, or other neurological disorders. The syndrome's recognition as a distinct clinical entity evolved slowly through the latter half of the twentieth century as researchers began cataloguing its characteristic progression.
Historical Narrative
The earliest systematic observations of what would eventually be called Rett syndrome were recorded in 1966 by Dr. Andreas Rett, a Viennese pediatric neurologist who noticed a remarkably similar pattern of behavior and regression in two girls sitting in his waiting room. Rett had previously observed comparable presentations in other young female patients and had begun documenting these cases as early as the 1960s. He published his initial findings in a German-language journal, but because the publication circulated within a limited academic community, his work attracted little international attention for nearly two decades. The condition he described was characterized by a period of apparently normal early development followed by a regression, but his reports remained largely unknown outside of German-speaking medical circles.
It was not until 1983 that the condition gained widespread recognition in the international medical community. Swedish neurologist Bengt Hagberg, along with colleagues from France and Portugal, published a landmark paper in the Annals of Neurology describing twenty-two cases of girls who exhibited a strikingly similar pattern of neurological deterioration. Hagberg and his collaborators were unaware of Rett's earlier work at the time of their own observations, and their publication brought the syndrome to the attention of researchers and clinicians across Europe and North America. Upon learning of Rett's prior documentation, the medical community formally named the condition Rett syndrome in honor of its original describer.
Following Hagberg's 1983 publication, a surge of clinical interest led researchers to revisit earlier case files and identify historical patients who had almost certainly been affected by the same condition but had been diagnosed with childhood schizophrenia, autism, or nonspecific encephalopathy. Medical historians noted that scattered case descriptions in earlier European neurological literature from the 1950s and even the 1940s bore features consistent with what Rett had described, though no unified framework had existed to connect these accounts.
Through the late 1980s and 1990s, researchers worked to establish standardized diagnostic criteria and to differentiate Rett syndrome from overlapping conditions, particularly autism spectrum disorders. International Rett syndrome conferences, beginning in the mid-1980s, brought together clinicians from multiple countries who had been independently accumulating case series. These gatherings proved instrumental in harmonizing observations and building a global registry of affected individuals.
The next major turning point came in 1999, when researchers Ruthann Schanen and Huda Zoghbi, building on years of genetic investigation, identified mutations in the MECP2 gene on the X chromosome as the underlying cause of the vast majority of classic Rett syndrome cases. Zoghbi's laboratory had been pursuing the genetic basis of the condition throughout the 1990s, and this discovery fundamentally transformed scientific understanding of the syndrome from a condition of unknown origin into one with a defined molecular basis. The identification of the MECP2 gene also explained why the syndrome appeared almost exclusively in females, given the lethality of the mutation in most males who lacked a second X chromosome to partially compensate.
This genetic breakthrough opened an entirely new chapter in Rett syndrome research, shifting the focus from clinical description toward understanding the molecular mechanisms by which MECP2 dysfunction affected neurological development. The history of Rett syndrome thus traced an arc from a overlooked case series in a Viennese waiting room to one of the most studied single-gene neurological conditions of the late twentieth century.
Key Historical Figures
Historical narrative only — this page describes how Rett syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.